SPOTLIGHT -
EP. 1: OncLive News Network On Location: In Chicago Friday, June 1
EP. 2: OncLive News Network On Location: In Chicago Saturday, June 2
EP. 3: OncLive News Network On Location: In Chicago Sunday, June 3
EP. 4: OncLive News Network On Location: In Chicago Monday, June 4
EP. 5: Practice Changes for Use of Immunotherapy in NSCLC
EP. 6: ASCO 2018: Dr. Borghaei Highlights Immunotherapy Findings in Lung Cancer
EP. 7: ASCO 2018: Dr. Esteva Highlights CDK4/6 Inhibitors and More in Breast Cancer
EP. 8: ASCO 2018: Dr. Burris Highlights TAILORx and More in Breast Cancer
EP. 9: ASCO 2018: Dr. Lonial Highlights CAR T-Cell Therapy and More in Myeloma
EP. 10: ASCO 2018: Dr. Weber Highlights Exciting Abstracts in Melanoma
EP. 11: ASCO 2018: Dr. Coleman Shares Insight on Ongoing Research in Ovarian Cancer
EP. 12: ASCO 2018: Dr. Bekaii-Saab Highlights Pancreatic Cancer Abstracts
EP. 13: ASCO 2018: Dr. Birrer on Practice-Changing Ovarian Cancer Studies
EP. 14: ASCO 2018: Dr. Westin Sheds Light on PARP Inhibitor Abstracts in Ovarian Cancer
EP. 15: KEYNOTE Trial Data: Pembrolizumab's Role in NSCLC
EP. 16: Actual Use of Pembrolizumab and Chemotherapy in NSCLC
EP. 17: CheckMate-227: Testing Ipilimumab/Nivolumab in NSCLC
EP. 18: IMPower150: Implications for the Treatment of NSCLC
EP. 19: Important Data in the Squamous NSCLC Population
EP. 20: Impact of Data on the Real-Life Treatment of NSCLC
EP. 21: Tumor Mutational Burden in NSCLC: Should it be Routine?
EP. 22: Optimizing Immunotherapy in the NSCLC Treatment Paradigm
EP. 23: Using Immunotherapy Beyond Progression in NSCLC
EP. 24: Practice Changes for Use of Immunotherapy in NSCLC: Q&A
Up-Front Osimertinib Provides Comparable OS, Improved Brain PFS Vs Sequential Gefitinib/Osimertinib in EGFR+ NSCLC
Dr Nasioudis on the Use of NGS to Identify the Molecular Profile of Endometroid Ovarian Cancer
Dr Buckingham on the Use of Patient-reported Outcomes to Predict Frailty in Patients With Ovarian Cancer
Dr Slomovitz on the Investigation of Letrozole Plus Ribociclib in Low-Grade Serous Ovarian Carcinoma